ProTrials Research

ProTrials Research

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

ProTrials Research is a well-established, privately-held clinical research organization (CRO) that provides end-to-end clinical development services to life sciences companies. With nearly three decades of operation, it has built a reputation for high-quality service delivery, deep therapeutic expertise, and a strong collaborative culture, evidenced by a high repeat business rate. The company leverages a global network of clinical operations personnel to manage trials across key therapeutic areas such as oncology, ophthalmology, CNS, infectious disease, and women's health, positioning itself as a trusted partner for biotech and pharma clients seeking experienced and integrated support.

OncologyOphthalmologyCentral Nervous SystemInfectious DiseaseWomen's HealthMedical Device & Diagnostics

Technology Platform

Operational service model leveraging experienced clinical research professionals and integrated processes for project management, clinical monitoring, data management, and quality assurance; offers Functional Service Provider (FSP) arrangements.

Opportunities

Growth in clinical trial outsourcing, especially the Functional Service Provider (FSP) model, provides a significant opportunity.
Expansion of complex trials in core therapeutic areas like oncology and CNS offers a chance to leverage deep expertise.
The growing biotech sector, which often lacks full internal clinical teams, represents a key target market for full-service CRO support.

Risk Factors

Faces intense competition from large global CROs and niche players.
Revenue is tied to client R&D budgets, which are cyclical and can be cut.
The business is highly dependent on recruiting and retaining skilled clinical personnel in a competitive labor market.

Competitive Landscape

Operates in the highly competitive global CRO market, competing against large public players (e.g., IQVIA, ICON, LabCorp) with broader scale and resources, as well as many small to midsize specialized CROs. Differentiates through deep therapeutic expertise, a high-touch service model, a strong focus on quality, and its status as a stable, woman-owned private company.